retatrutide clinical trials news CT Health | Doctors are warning patients against using unapproved versions of retatrutide, an experimental Eli Lilly weight loss drug still in Retatrutide—A Game Changer in Obesity

These medicines are most often given as weekly or daily injections, though some are available in oral form

Kaiser family foundation

First-time prescribing of AOMs was about the same in December 2025, relative to September 2025 (-1.0%)

GLP-1 medications are no different: The National Institutes of Health has concluded that they do not present any significant safety issues when prescribed and monitored by a healthcare provider

Glucagon-Like Peptide-1 Receptor Agonists and Optic Nerve Ischemia . National Library of Medicine

Potential risks include: Loss of lean muscle mass instead of fat Nutritional deficiencies due to appetite suppression Side effects like nausea, vomiting, and fatigue Increased risk of gallbladder disease Weight Loss Injections for Fitness Goals Many people seeking weight loss injections for fitness goals are looking to shed small amounts of weight for aesthetic or athletic reasons